Retrieved 13 October 2021
In findings from the Semaglutide Cardiovascular Outcomes Trial (SOUL) recently published in the New England Journal of Medicine , investigators reported that the use of oral semaglutide was associated with a significantly lower risk of major adverse cardiovascular events than a placebo, without an increase in the incidence of serious adverse events, in people with type 2 diabetes and atherosclerotic cardiovascular disease, chronic kidney disease, or both
Facility overhead, program fees, and consultation charges stack on top of medication costs in ways that telehealth doesnt
Most patients begin to notice results within two to four weeks, with the most significant changes appearing between weeks four and eight under a properly managed treatment plan
If you are uncertain about what to do after missing a dose, contact your healthcare provider or pharmacist for personalized guidance
Mounjaro is designed as a long-term treatment, and stopping is not always the right next step once you reach your goal